Ataraxis AI Scales Medical Foundation Model to Falcon, Expands Cancer Clinical Use

kjgeras · x · 2026-07-06

Medical AI company Ataraxis AI has upgraded its foundation model from Kestrel to Falcon (1.1 billion parameters, 2 billion patches), expanding its application scope from predicting cancer recurrence risk to assisting in evaluating chemotherapy benefits and predicting neoadjuvant therapy responses. Based on AI analysis of pathology slides, the company continues to advance clinical decision support for breast cancer, with more results to be announced soon.

Related event: Multimodal AI Pathology Test Outperforms Gold Standard in Breast Cancer Recurrence Prediction(11 posts)→

Original post →

More from Research

Research channel →